Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fletcher

Showing results (171-180 of 326) with videos related to

Pageof 33
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 21, 2021
Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected IndividualsTozammel M D Hoque, Amélie Cattin, Sana-Kay Whyte-Allman, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapyC V Fletcher, R C Brundage, R P Remmel, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 15, 2020
Effect of continuous positive airway pressure on maximal exercise capacity in patients with obstructive sleep apnea: a systematic review and meta-analysisHannah V Fletcher, Peter S P Cho, Stewart Lee Loong, et al.
AIDS (London, England)|November 4, 2000
Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected personsC V Fletcher, S P Kawle, T N Kakuda, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Clinical Pharmacology and Therapeutics|May 10, 2020
The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected PersonsCourtney V Fletcher, Anthony T Podany, Ann Thorkelson, et al.
Scientific Reports|February 28, 2018
Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assayShetty Ravi Dyavar, Zhen Ye, Siddappa N Byrareddy, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1994
Foscarnet for suppression of human immunodeficiency virus replicationC V Fletcher, A C Collier, F S Rhame, et al.
AIDS (London, England)|September 22, 2007
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infectionDavid M Margolis, A Lisa Mukherjee, Courtney V Fletcher, et al.
AIDS (London, England)|January 16, 2018
Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamideAnthony T Podany, Sara H Bares, Joshua Havens, et al.
Pageof 33

Showing results (171-180 of 326) with videos related to

Sort By:
Pageof 33
Journal of Acquired Immune Deficiency Syndromes (1999)|June 21, 2021
Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected IndividualsTozammel M D Hoque, Amélie Cattin, Sana-Kay Whyte-Allman, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapyC V Fletcher, R C Brundage, R P Remmel, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 15, 2020
Effect of continuous positive airway pressure on maximal exercise capacity in patients with obstructive sleep apnea: a systematic review and meta-analysisHannah V Fletcher, Peter S P Cho, Stewart Lee Loong, et al.
AIDS (London, England)|November 4, 2000
Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected personsC V Fletcher, S P Kawle, T N Kakuda, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Clinical Pharmacology and Therapeutics|May 10, 2020
The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected PersonsCourtney V Fletcher, Anthony T Podany, Ann Thorkelson, et al.
Scientific Reports|February 28, 2018
Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assayShetty Ravi Dyavar, Zhen Ye, Siddappa N Byrareddy, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1994
Foscarnet for suppression of human immunodeficiency virus replicationC V Fletcher, A C Collier, F S Rhame, et al.
AIDS (London, England)|September 22, 2007
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infectionDavid M Margolis, A Lisa Mukherjee, Courtney V Fletcher, et al.
AIDS (London, England)|January 16, 2018
Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamideAnthony T Podany, Sara H Bares, Joshua Havens, et al.
Pageof 33